A study to investigate efficacy of neoadjuvant Sorafenib treatment on tumor cluster shedding in patients with renal cell carcinoma.
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2014
At a glance
- Drugs Sorafenib (Primary)
- Indications Renal cancer; Renal cell carcinoma
- Focus Biomarker; Therapeutic Use
- 05 Mar 2010 Results were presented at the ASCO 2010 Genitourinary Cancers Symposium.
- 05 Mar 2010 New trial record